In-vivo study: the maximal systolic acceleration in a modified arterial stenosis

Completed

• Conditions: claudicatio intermittens; Peripheral arterial disease; 10003216

• Registration Number: NL-OMON47006
• Lead Sponsor: Vaatchirurgie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

Healthy test subjects between 18 and 30 years old.

Exclusion Criteria

Test subjects with peripheral arterial disease, diabetes mellitus, renal insufficiency, Raynaud's phenomenon.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Ankle-brachial index (ABI), toe pressure and maximal systolic acceleration (ACC<br /><br>max).</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Niet van toepassing.</p><br>